We are live on ! Find out more
SZYM

SOLAZYME INC COM STK (DE)
SZYM

Delisted

SZYM was delisted on the 10th of May, 2016.

124 hedge funds and large institutions have $523M invested in SOLAZYME INC COM STK (DE) in 2014 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 74 increasing their positions, 18 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

311% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 18

15% more capital invested

Capital invested by funds: $456M → $523M (+$66.9M)

11% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 18

2% more funds holding

Funds holding: 122124 (+2)

60% less call options, than puts

Call options by funds: $5.15M | Put options by funds: $12.9M

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
124
Holders Change
+2
Holders Change %
+1.64%
% of All Funds
3.56%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
20
Increased
74
Reduced
18
Closed
18
Calls
$5.15M
Puts
$12.9M
Net Calls
-$7.78M
Net Calls Change
-$4.31M
Name Holding Trade Value Shares
Change
Change in
Stake
Primecap Management
1
Primecap Management
California
$107M +$9.99M +937,220 +11%
PC
2
Passport Capital
California
$75.8M +$9.67M +906,850 +16%
Vanguard Group
3
Vanguard Group
Pennsylvania
$37.2M +$1.14M +106,760 +3%
State Street
4
State Street
Massachusetts
$28M +$8.15M +764,785 +47%
BIT
5
BlackRock Institutional Trust
California
$21.7M +$3.82M +358,205 +24%
BFA
6
BlackRock Fund Advisors
California
$20.6M +$5.32M +499,029 +40%
Artisan Partners
7
Artisan Partners
Wisconsin
$19.8M +$2.58M +242,047 +17%
Point72 Asset Management
8
Point72 Asset Management
Connecticut
$16.3M +$14.7M +1,381,609 New
Lazard Asset Management
9
Lazard Asset Management
New York
$15M +$9.4M +881,365 +226%
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$12.6M -$699K -65,540 -6%
WF
11
Welch & Forbes
Massachusetts
$11.2M +$690K +64,685 +7%
Morgan Stanley
12
Morgan Stanley
New York
$8.74M +$951K +89,207 +14%
BA
13
BlackRock Advisors
Delaware
$8.33M +$1.65M +154,420 +28%
Northern Trust
14
Northern Trust
Illinois
$8.11M +$900K +84,419 +14%
Invesco
15
Invesco
Georgia
$7.51M +$282K +26,493 +4%
RA
16
Royce & Associates
New York
$7.27M +$2.84M +266,218 +76%
AGA
17
Altrinsic Global Advisors
Connecticut
$6.83M +$460K +43,100 +8%
UBS AM
18
UBS AM
Illinois
$6.53M -$286K -26,827 -5%
T
19
Tahithromos
New York
$6.21M +$5.62M +527,475 New
IHL
20
Investment House LLC
California
$5.85M +$20.8K +1,950 +0.4%
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
$5.83M +$404K +37,939 +8%
BKBG
22
BHF Kleinwort Benson Group
Belgium
$4.63M +$1.84M +172,691 +78%
EAM
23
Eventide Asset Management
Massachusetts
$4.53M +$217K +20,400 +6%
Geode Capital Management
24
Geode Capital Management
Massachusetts
$4.11M +$592K +55,566 +19%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$4.1M +$1.25M +117,343 +51%

SZYM Hedge Fund Activity: Q2 2014 in Review

124 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in SOLAZYME INC COM STK (DE) (SZYM) for Q2 2014, worth a combined $523M — up 15% from $456M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new SZYM positions and 18 closed out — a net gain of 2 holders — while 74 added to existing stakes and 18 trimmed.

The largest buyer was Primecap Management, adding an estimated $9.99M. The largest seller was Fidelity Investments, exiting entirely with an estimated $13.3M sold.

  • 124 institutional investors held SOLAZYME INC COM STK (DE) (SZYM) as of Q2 2014, up from 122 in Q1 2014.
  • Funds reported $523M of SOLAZYME INC COM STK (DE) stock for Q2 2014, up 15% quarter-over-quarter.
  • 20 funds opened new SOLAZYME INC COM STK (DE) positions in Q2 2014 and 18 closed out, a net change of +2 holders.
  • The largest SOLAZYME INC COM STK (DE) buyer in Q2 2014 was Primecap Management, an estimated $9.99M added.
  • The largest SOLAZYME INC COM STK (DE) seller in Q2 2014 was Fidelity Investments, an estimated $13.3M sold.

Based on aggregated 13F filings for Q2 2014.